松龄血脉康对1级高血压合并睡眠障碍患者的临床疗效

目的:探讨松龄血脉康对1级高血压合并睡眠障碍患者生活质量及临床疗效的影响。方法:收集我院收治的150例1级高血压合并睡眠障碍患者,随机分为实验组和对照组,每组75例。对照组患者给予硝苯地平缓释片并结合低盐饮食,减少脂肪摄入,减轻体重,增加体育活动等。实验组患者在对照组患者基础上给予松龄血脉康胶囊。观察并比较两组患者的治疗前后血压、生活质量水平以及患者睡眠障碍、高血压的临床疗效。结果:与治疗前相比,两组患者治疗后收缩压、舒张压水平均下降,生活质量评分均升高,差异具有统计学意义(P0.05);与对照组相比,实验组患者收缩压、舒张压水平较低,生活质量评分、睡眠障碍以及高血压的治疗有效率较高,差异具有统计学意义(P0.05)。结论:松龄血脉康能够降低1级高血压合并睡眠障碍患者血压水平,提高其生活质量,提高治疗效果。     

单纯治疗慢性前列腺炎对其合并早泄的影响

目的:探讨单纯治疗慢性前列腺炎对其合并早泄的影响。方法:选择372例前列腺炎继发早泄的患者进行单纯针对前列腺炎的治疗,评价前列腺炎的治疗效果(包括前列腺炎症状评分(NIH-CPSI)、前列腺液常规等)及早泄的治疗效果(包括患者性生活满意度评分、配偶性生活满意度评分及阴道内射精潜伏期等)。结果:慢性前列腺炎经综合治疗后,患者的NIH-CPSI评分及前列腺液白细胞计数均显著降低(P0.05)。前列腺炎治愈或好转后,大多数患者的早泄情况得到明显改善,患者性生活满意度、配偶性生活满意度均较治疗前显著提高,阴道内射精潜伏期亦较治疗前明显延长,差异均具有统计学意义(P0.05)。结论:单纯治疗慢性前列腺炎继可使大部分患者并发的早泄明显改善,而对少数前列腺炎好转后早泄症状改善不明显者,可联合应用SSRIs等药物治疗。     

维持性血液透析患者睡眠质量的影响因素及与氧化应激水平、生活质量和疲乏状况的关系研究

摘要 目的：分析调查维持性血液透析（MHD）患者睡眠质量的影响因素,并分析其与生活质量、氧化应激水平和疲乏状况的关系。方法：研究对象选取自2019年8月~2021年5月在首都医科大学附属北京朝阳医院血液透析室长期规律行MHD治疗的终末期肾脏病患者150例,收集患者的临床资料,采用匹兹堡睡眠指数（PSQI）量表评定睡眠质量。采用修订版Pieper疲劳量表（RPFS）评估所有患者的疲乏程度。采用肾脏病生活质量量表（KDQOL-SF）评估患者生活质量。分析MHD患者睡眠质量的影响因素,并分析其与氧化应激水平、生活质量和疲乏状况的关系。结果：150例MHD患者中有114例PSQI评分>5分,本血液透析室MHD患者睡眠障碍发生率为76.00% (114/150)。根据是否发生睡眠障碍将患者分为睡眠障碍组（n=114）和无睡眠障碍组（n=36）。单因素分析结果显示睡眠障碍组、无睡眠障碍在年龄、透析时间、血红蛋白（Hb）、血清甲状旁腺激素（iPTH）、透析治疗效率标准（Kt/V）、血钙方面组间对比有差异（P<0.05）。透析时间、年龄、Hb、iPTH、Kt/V均是MHD患者睡眠质量的影响因素（P<0.05）。睡眠障碍组的一般健康状况、肾病相关、总分均低于无睡眠障碍组（P<0.05）。睡眠障碍组的疲乏评分高于无睡眠障碍组（P<0.05）。睡眠障碍组的丙二醛（MDA）高于无睡眠障碍组,超氧物歧化酶（SOD）、人谷胱甘肽-过氧化物酶（GSH-Px）低于无睡眠障碍组（P<0.05）。结论：透析时间、年龄、Hb、iPTH、Kt/V均是MHD患者睡眠质量的影响因素,且睡眠质量变差会加重MHD患者疲乏程度,加重氧化应激反应,降低患者的生活质量。     

帕金森病睡眠障碍发病机制及其治疗的研究进展

睡眠障碍是帕金森病常见并发症,严重影响患者的生活质量。主要从帕金森病患者睡眠障碍的表现形式、发病机制及治疗策略 等 3 个方面综述帕金森病睡眠障碍研究的最新进展,旨在为其进一步研究提供参考。     

国内外信息

战永胜首创“双效雄露”获国家专利中国蛇协会员,广西南宁乾坤宝天然保健品厂总工程师战永胜研究成功一种治疗男子性功能障碍早泄并能防治淋病双向功效保健品——“乾坤宝双效雄露”最近通过省级技术成果鉴定,该产品为中草药制剂,技术新颖,患者使用方便,已获中国发明专利。经药理研究,该产品可抒制性兴奋传导,有利于建立良性的性反应,消除早泄患者的精神焦虑,达到治疗早泄的目的;同时该产品为广谱性抗菌剂,对近20种病菌,病毒、特别是淋病双球菌有特强的灭杀作     

针刺联合黄连温胆汤治疗脑卒中后轻度认知功能障碍的临床疗效研究

目的:探讨针刺联合黄连温胆汤治疗脑卒中后轻度认知功能障碍的临床疗效。方法:选择2013年6月至2016年8月在我院进行治疗的脑卒中后轻度认知功能障碍患者100例,随机分为两组,每组50例。对照组患者服用尼莫地平,观察组患者在对照组基础上服用黄连温胆汤并配合针刺治疗。评价和比较两组患者治疗前后的简易精神状态量表(MMSE)以及改良爱丁堡-斯堪的纳维亚神经功能缺损评分量表(MSSS)评分,治疗后神经功能障碍和认知功能障碍的临床疗效及生活质量。结果:治疗后,两组患者的MMSE、ADL评分均较治疗前显著降低(P0.05),且观察组降低的程度显著高于对照组(P0.05);两组患者的MSSS、MBI评分显著升高(P0.05),且观察组升高程度显著高于对照组(P0.05)。观察组患者经治疗后的认知功能障碍及神经功能障碍临床疗效的总有效率均显著高于对照组(P0.05)。结论:黄连温胆汤联合针刺用于治疗脑卒中后轻度认知功能障碍临床疗效显著,且可显著改善患者生活质量。     

终末期肾脏病患者睡眠质量的影响因素及其与生活质量、焦虑抑郁的关系研究

目的:探讨终末期肾脏病(ESRD)患者睡眠质量的影响因素及其与生活质量、焦虑抑郁的关系。方法:选取2018年3月~2019年12月期间我院收治的ESRD患者198例为研究对象。患者睡眠质量采用匹兹堡睡眠指数量表(PSQI)评价。采用焦虑自评量表(SAS)与抑郁自评量表(SDS)评估患者焦虑、抑郁状态。采用肾病生活质量评价量表(KDQOL-SF1.2)评价患者生活质量。分析ESRD患者睡眠质量的影响因素,并分析睡眠质量与生活质量、焦虑抑郁的相关性。结果:ESRD患者中约有93例发生睡眠障碍,睡眠障碍发生率为46.97%(93/198),并将其纳入睡眠障碍组,剩余的105例纳入非睡眠障碍组。非睡眠障碍组KDQOL-SF 1.2评分高于睡眠障碍组,SAS评分、SDS评分则低于睡眠障碍组(P<0.05)。单因素分析结果显示,两组年龄、透析龄、血红蛋白、甲状旁腺激素(iPTH)、血肌酐(Scr)、血钙、血磷比较差异显著(P<0.05),两组性别、配偶、经济收入、文化程度、血清白蛋白、尿素氮(BUN)比较差异无统计学意义(P>0.05)。多重线性回归方程结果显示,年龄、透析龄、血红蛋白、iPTH、Scr、血钙、血磷均是ESRD患者睡眠障碍的影响因素(P<0.05)。PSQI评分与SAS评分、SDS评分均呈正相关,与KDQOL-SF 1.2评分呈负相关(P<0.05)。结论:ESRD患者睡眠障碍的发生率高,年龄、透析龄、血红蛋白、iPTH、Scr、血钙、血磷均是ESRD患者睡眠质量的影响因素,同时其睡眠质量与生活质量、焦虑抑郁具有一定的相关性。     

老年髋部骨折患者术后功能恢复护理研究进展

<正>随着我国人口老龄化的加剧,老年髋部骨折率呈逐年增长趋势。髋部骨折是引起老年行动障碍的常见原因[1]。近年来在老年髋部骨折的治疗上多倾向手术治疗,手术治疗具有并发症少、病死率低、患者恢复快等特点。但相关研究发现,老年髋部骨折患者术后4~12个月日常活动能力及髋关节功能均无法完全恢复到骨折前水平,对患者日常生活质量影响较大。如果老年髋部骨折患者出院后持久出现生活能力障碍,可造成患者预期寿命减少。因此,老年髋部骨折患     

癫痫与认知功能

癫痫是神经系统最常见的疾病之一,以反复的自发发作为特征,还伴随着对认知,心理以及社交的影响。相比一般人群,癫痫患者更容易罹患认知和行为的障碍,认知障碍在新诊断的部分或者全面性癫痫发作的成人癫痫患者中均有报道。癫痫发作类型、病因、神经病理、发作类型、发作年龄、社会心理问题等一系列因素都和认知功能障碍相关,而且目前癫痫主要的治疗方法（如抗癫痫药物治疗和外科手术）也和认知及行为障碍相关。对于这些与治疗相关的副作用,临床治疗应该警惕并且尽量避免或者缩小负面的影响。本文从生物学因素、心理社会学因素及治疗相关的因素三个方面综述了癫痫与认知障碍之间的关系,为临床治疗和预防癫痫提供指导。     

癫痫与认知功能

癫痫是神经系统最常见的疾病之一,以反复的自发发作为特征,还伴随着对认知,心理以及社交的影响.相比一般人群,癫痫患者更容易罹患认知和行为的障碍,认知障碍在新诊断的部分或者全面性癫痫发作的成人癫痫患者中均有报道.癫痫发作类型、病因、神经病理、发作类型、发作年龄、社会心理问题等一系列因素都和认知功能障碍相关,而且目前癫痫主要的治疗方法(如抗癫痫药物治疗和外科手术)也和认知及行为障碍相关.对于这些与治疗相关的副作用,临床治疗应该警惕并且尽量避免或者缩小负面的影响.本文从生物学因素、心理社会学因素及治疗相关的因素三个方面综述了癫痫与认知障碍之间的关系,为临床治疗和预防癫痫提供指导.     

Définition et épidémiologie des troubles de l'éjaculation

Ejaculatory dysfunction is a male sexual disorder and comprises premature ejaculation, delayed ejaculation, anorgasmia, anejaculation and retrograde ejaculation. The definition of premature ejaculation is based on three essential criteria: brief ejaculatory latency, loss of control and psychological distress for the patient and/or his partner. Comparison of studies on premature ejaculation is difficult due to the absence of physiological data in the general population on ejaculatory latency, the absence of a precise definition of premature ejaculation and the absence of a questionnaire or standardized and valldated methods of evaluation. However, the rare studies performed since 1990 show high prevalences: about 10% of menoften or always experience premature ejaculation. The prevalence of delayed ejaculation and anorgasmia is estimated to be between 5 and 10%. Ejaculatory dysfunctions are therefore significant health problems with consequences on sexuality, fertility and quality of life.     

Prise en charge actuelle de l’ejaculation prematuree

Considered as the most common male sexual problem, premature ejaculation is characterized by the absence of control over the ejaculatory reflex with a correspondingly poor perception of sexual arousal and pleasure. After first considering the nature of the problems underlying premature ejaculation, this article emphasizes the relevance of pathophysiological aspects and considers the main treatments available according to the various contributory factors identifiable during investigation in relation to whether the problem is structural or psychological. Successful treatments is dependent upon modifying and correcting the mental and sensory processes of the premature ejaculator during his sexual activity. When premature ejaculation is an isolated symptom without a concomitant psychological problem, it may be considered a sexual learning disability and has excellent prognosis with sex therapy using behavioural methods (“squeeze technique”, “start-stop technique”). In other cases, the symptom of premature ejaculation is associated with deeper psychological problems and treatment requires a more complex psychodynamic approach, but one which does not exclude behavioural measures when appropriate.     

Current concepts in ejaculatory dysfunction

Although erectile dysfunction has recently become the most well-known aspect of male sexual dysfunction, the most prevalent male sexual disorders are ejaculatory dysfunctions. Ejaculatory disorders are divided into 4 categories: premature ejaculation (PE), delayed ejaculation, retrograde ejaculation, and anejaculation/anorgasmia. Pharmacologic treatment for certain ejaculatory disorders exists, for example the off-label use of selective serotonin reuptake inhibitors for PE. Unfortunately, the other ejaculatory disorders are less studied and not as well understood. This review revisits the physiology of the normal ejaculatory response, specifically explores the mechanisms of anejaculation, and presents emerging data. The neurophysiology of the ejaculatory reflex is complex, making classification of the role of individual neurotransmitters extremely difficult. However, recent research has elucidated more about the role of serotonin and dopamine at the central level in the physiology of both arousal and orgasm. Other recent studies that look at differing pharmacokinetic profiles and binding affinities of the alpha(1)-antagonists serve as an indication of the centrally mediated role of ejaculation and orgasm. As our understanding of the interaction between central and peripheral modulations and regulation of the process of ejaculation increases, the probability of developing centrally acting pharmaceutical agents for the treatment of sexual dysfunction approaches reality.     

盐酸达泊西汀联合他达拉非治疗原发性早泄的临床研究

目的:探讨盐酸达泊西汀联合他达拉非治疗原发性早泄的疗效。方法:将100例患者随机分成治疗组和对照组,每组50例。治疗组口服他达拉非片5 mg,每天1次,性交前按需口服盐酸达泊西汀片30 mg。对照组只按需口服盐酸达泊西汀片30 mg。疗程2个月。治疗期间嘱患者进行规律的性生活,每周1-2次,并做好相关记录。治疗前后行阴道内射精潜伏期(intravaginal ejaculation latency,IELT)IELT测评、患者及配偶性生活满意度评分。结果:与治疗前相比,两组治疗后IELT、患者及配偶满意度均有明显改善,差异具有统计学意义(P0.05)。而且治疗后治疗组与对照组比较,治疗组的IELT、患者及配偶满意度改善更为明显,差异亦具有统计学意义(P0.05)。常见不良反应有颜面潮红、头晕、鼻塞,无需特殊处理,症状均自行缓解。结论:盐酸达泊西汀联合他达拉非治疗原发性早泄安全有效。     

Blessé médullaire: prise en charge en andrologie

Sexual reactions are under neurological control. Spinal cord trauma alters neurological structure and induces sexual dysfunction. Pharmacological drugs used currently allow erectile function to be recovered in spinal cord-injured men, an essential step towards the resumption of a sex life. Triggering of ejaculation is often difficult. Perineal stimulation techniques, used either in isolation or in association with pharmacological treatment, promote ejaculation and allow sperm collection and freezing. The possibility of achieving ejaculation during sexual intercourse in spinal cord-injured men remains rare and there is as yet no real therapy available. Despite poor semen quality, spinal cord-injured men maintain reproductive possibilities in 40 to 60% of couples. The use of assisted reproductive technologies is often required. Management of sexual dysfunction in spinal cord-injured men must be integrated into a rehabilitation and re-insertion programme.     

Le recueil de sperme chez le blessé médullaire

Infertility is a major issue for men with spinal cord injury (SCI). Male infertility is due to a combination of ejaculatory dysfunction and abnormal sperm quantity and quality. The reported ability to ejaculate during sexual stimulation or masturbation is about 15%. Techniques to remediate ejaculation have vastly improved the fertility potential of men with SCI. Penile vibratory stimulation (PVS) to induce ejaculation is now recommended as first-line treatment due to its safety and relative efficacy. PVS can also be used at home for fertility purposes with success rates of more than 70%. Pharmacological treatments can be associated with PVS to enhance ejaculation. Midodrine, an alpha1-adrenergic agonist, has been recently used with success rates of 66% in SCI patients who failed PVS alone. PVS with midodrine can now be considered as second-line treatment for anejaculation, after PVS and before electroejaculation. It is a safe procedure, but requires cardiovascular monitoring. PVS with midodrine can also be effective in the treatment of retrograde ejaculation by inducing bladder neck closure.     

Prostatite chronique, syndrome douloureux pelvien chronique et dysfonctions sexuelles

In 1995, the NIH (National Institutes of Health, USA) proposed a new classification of chronic prostatitis (CP), no longer considered in the strict framework of the prostate, but based on the concept of pelvic pain. This classification introduced the term chronic pelvic pain syndrome (CPPS). The definition of this syndrome indicates that pain is sometimes associated with sexual disorders. Many surveys have demonstrated the considerable prevalence of CP/CPPS and have confirmed the impact of these diseases on quality of life, but only limited epidemiological data concerning the links between CP/CPPS and sexuality are available at the present time. The pathophysiology of sexual dysfunction associated with CP/CPPS (alteration of desire, erectile dysfunction and premature ejaculation) also remains poorly elucidated. A psychological factor is very probably involved, but many uncertainties persist concerning the other mechanisms possibly involved.     

Managing early ejaculation: what does the future hold?

Recent attention in the field of male sexual dysfunction has focused on erectile dysfunction. However, premature ejaculation (PE) is an extremely common condition that warrants clinical study and exploration of pharmacologic treatments. Until recently, PE was thought to be a behavioral problem for which the best remedy was a learned control technique. However, some drugs currently on the market, including sildenafil and the selective serotonin reuptake inhibitors, appear to have efficacy in the treatment of PE. More research is needed before FDA approval of such agents for this indication, but more and better options for men with PE are anticipated as attention to ejaculatory disorders grows and, hopefully, the associated stigma decreases.     

Sexual Therapy of Patients with Cardiovascular Disease

Physical illness or disability inevitably has a damaging effect on sexual relationships. Physicians are usually unaware of the sexual consequences of illness on their patients, and lack experience in treating sexual dysfunctions.The report of treatment of a couple with serious cardiovascular disease illustrates the potential efficacy of brief sex therapy for improving the quality of a patient''s life. If a primary physician lacks the skills to conduct sex therapy, he may collaborate with nonphysician therapists. The physician''s knowledge of the physiological and psychological effects of a specific illness on his patient is essential to successful therapy. Often, simple education, encouragement or reassurance by the physician is enough to overcome the damaging effects of illness on a patient''s sex life.